Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Gallenga PE, Lobefalo L, Colangelo L, Della Loggia G, Orzalesi N, Velati P, Bujtar E, Ponte F, Damiani S, Bucci MG, Bonini S, Curatola MR, Palma LA, Bonomi L, Tomazzoli Gerosa L, Pagliarusco A, Milan E, Jauch A.
Gallenga PE, et al. Among authors: bujtar e.
Ophthalmologica. 1999;213(4):250-7. doi: 10.1159/000027430.
Ophthalmologica. 1999.
PMID: 10420109
Clinical Trial.